Weekly Topotecan for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Tolerability and Efficacy Study—The Israeli Experience

Tamar Safra; Tara Berman; Adelya Yachnin; Ilan Bruchim; Mihai Meirovitz; Frida Barak; Ilan Atlas; Tally Levy; Ora Solange Rosengarten

doi:10.1097/IGC.0b013e3182866944

Article info

Ovarian Cancer

Weekly Topotecan for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Tolerability and Efficacy Study—The Israeli Experience

Authors

Tamar Safra Department of Oncology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; PubMed articles Google scholar articles
Tara Berman Department of Internal Medicine, St Luke’s–Roosevelt Hospital Center, New York, NY; PubMed articles Google scholar articles
Adelya Yachnin Department of Oncology, Kaplan Medical Center, Rehovot and Faculty of Medicine, Hebrew University, Jerusalem; PubMed articles Google scholar articles
Ilan Bruchim Gyneco-oncology Division, Meir Medical Center, Kfar Saba and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; PubMed articles Google scholar articles
Mihai Meirovitz Unit of Gyneco-oncology, Soroka University Medical Center and Ben Gurion University; PubMed articles Google scholar articles
Frida Barak Oncology Institute, Barzilai Medical Center, Ashkelon and Ben Gurion University, Beer Sheva; PubMed articles Google scholar articles
Ilan Atlas Gynecological Oncology Unit, Baruch Pedah Medical Center, Poria and Faculty of Medicine, Bar Ilan University, Ramat Gan; PubMed articles Google scholar articles
Tally Levy Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Wolfson Medical Center, Holon and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; and PubMed articles Google scholar articles
Ora Solange Rosengarten Department of Internal Medicine, St Luke’s–Roosevelt Hospital Center, New York, NY;Department of Oncology, Kaplan Medical Center, Rehovot and Faculty of Medicine, Hebrew University, Jerusalem; PubMed articles Google scholar articles

Address correspondence and reprint requests to Tamar Safra, MD, Oncology Department, Tel Aviv Sourasky Medical Center, 6 Weizmann St. Tel Aviv 64239, Israel. E-mail: safrat{at}bezeqint.net.

Citation

Safra T, Berman T, Yachnin A, et al

Weekly Topotecan for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Tolerability and Efficacy Study—The Israeli Experience

International Journal of Gynecologic Cancer 2013;23:475-480.

Publication history

Received October 28, 2012
Accepted January 7, 2013
First published March 1, 2013.

Online issue publication

February 25, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password